Search

Issue
Title
Authors
Immunotherapy of Malignant Gliomas Using Autologous and Allogeneic Tissue Cells
M. Hofman F., Stathopoulos A., A. Kruse C., C. Chen T., E.J.C. Schijns V.
Circulating Tumor Cells: A New Window for Diagnosis and Evaluation of Cancer
Liu M., Tang M., Li M., Gao F., Shi C., Hou J., Zeng W.
Application of dsRNA in Cancer Immunotherapy: Current Status and Future Trends
Jin B., Cheng L., Wu K., Yu X., Yeo A.
The Immune System in Cancer Prevention, Development and Therapy
Candeias S., Gaipl U.
Therapeutic Exploitation of Apoptosis and Autophagy for Glioblastoma
Kogel D., Fulda S., Mittelbronn M.
Targeting Cancer Stem Cells: Promises and Challenges
Kuhlmann J., Hein L., Kurth I., Wimberger P., Dubrovska A.
Tumor Promoters - Microcystin-LR, Nodularin and TNF-α and Human Cancer Development
Fujiki H., Suganuma M.
Ozone Dosage Effect on C6 Cell Growth: in Vitro and in Vivo Tests
Pérez A., Santos Cuevas C., Chairez I., Poznyak T., Ordaz-Rosado D., García-Becerra R., Romero Piña M.
Tapasin and Human Leukocyte Antigen Class I Dysregulation Correlates with Survival in Glioblastoma Multiforme
Thuring C., Geironson L., Paulsson K.
Therapeutic Vaccines Explored in Patients with Non-Small Cell Lung Cancer
Ma K., Tang Y.
Quinones Derived from Plant Secondary Metabolites as Anti-cancer Agents
Lu J., Bao J., Wu G., Xu W., Huang M., Chen X., Wang Y.
A Novel Fusicoccin Derivative Preferentially Targets Hypoxic Tumor Cells and Inhibits Tumor Growth in Xenografts
Kawakami K., Hattori M., Inoue T., Maruyama Y., Ohkanda J., Kato N., Tongu M., Yamada T., Akimoto M., Takenaga K., Sassa T., Suzumiy J., Honma Y.
Angiogenesis in Glioblastoma Multiforme: Navigating the Maze
G. Linkous A., M. Yazlovitskaya E.
Emerging Therapeutic Targets and Agents for Glioblastoma Migrating Cells
Di C., K. Mattox A., Harward S., Adamson C.
Gliomagenesis and the Use of Neural Stem Cells in Brain Tumor Treatment
Achanta P., Sedora Roman N., Quinones-Hinojosa A.
Novel Synthetic Indazoles Abrogate Angiogenesis in Erlich Ascites Tumor Bearing Mice
Ashwini N., Balaji K., Sadashivaiah B., Swaroop T., Jayarama S., Mantelingu K., Rangappa K.
CRD-BP as a Tumor Marker of Colorectal Cancer
Fen-Xu , Jiang L., Chen-Fu , Feng W., Zhou C.
Immunotherapeutic Impact of Toll-like Receptor Agonists in Breast Cancer
Zhang C., Ben A., Reville J., Calabrese V., Villa N., Bandyopadhyay M., Dasgupta S.
HLA-I Antigen Presentation and Tapasin Influence Immune Responses Against Malignant Brain Tumors-Considerations for Successful Immunotherapy
Darabi A., Thuring C., Paulsson K.
Metformin: A Rising Star to Fight the Epithelial Mesenchymal Transition in Oncology
Barriere G., Tartary M., Rigaud M.
The Cytotoxic Effect of Emetine and CGP-74514A Studied with the Hollow Fiber Model and ArrayScan Assay in Neuroendocrine Tumors In Vitro
E. Larsson D., B. Hassan S., Oberg K., Granberg D.
Cell Contact/Adhesion Proteins Lgl and DFak56: Tumorigenic and Whole-Organism Vital Effects Studied in Drosophila
Ya. Weisman N., D. Golubovsky M.
Epidermal Growth Factor Receptor as a Target for Anti-Cancer Agent Design
Cao J., Fang H., Wang B., Ma C., Xu W.
Cilengitide: The First Anti-Angiogenic Small Molecule Drug Candidate. Design, Synthesis and Clinical Evaluation
Mas-Moruno C., Rechenmacher F., Kessler H.
STAT3 Signaling Axis and Tamoxifen in Breast Cancer: A Promising Target for Treatment Resistance
Zamanian M.Y., Golmohammadi M., Alalak A., Kamiab Z., Obaid R., Ramírez-Coronel A., Hjazi A., Abosaooda M., Mustafa Y., Heidari M., Verma A., Nazari Y., Bazmandegan G.
Immunomodulatory Roles of IL-15 in Immune Cells and its Potential for Cancer Immunotherapy
Liu Y., Ma W., Tian X., Wang Q., Lu X., Luo Y., Xu J.
A Role for the Inflammatory Mediators Cox-2 and Metalloproteinases in Cancer Stemness
Chimal-Ramírez G., Espinoza-Sanchez N., Fuentes-Panana E.
Overcoming the Blood-Brain Barrier for Chemotherapy: Limitations, Challenges and Rising Problems
Wang Z., Sun H., Yakisich J.
Differential Effects of Antofine N-Oxide on Solid Tumor and Leukemia Cells
Bour T., Yang X., Li W., Bernardin F., Kaoma T., Muller A., Vallar L., Steinmetz A.
Cell Dormancy and Tumor Refractory
Yu Y., Zhu Z.
Chemoinformatics in Multi-target Drug Discovery for Anti-cancer Therapy: In Silico Design of Potent and Versatile Anti-brain Tumor Agents
Speck-Planche A., V. Kleandrova V., Luan F., Natalia D. S. Cordeiro M.
FAK and p53 Protein Interactions
M. Golubovskaya V., G. Cance W.
Obesity Modulation - The Role in Carcinogenesis
Legakis I., Syrigos K.
Focal Adhesion Kinase as a Cancer Therapy Target
M. Golubovskaya V.
Managing Cancer Treatment in Patients with Renal Dysfunction: The Role of Chemotherapy
Aghsaeifard Z., Alizadeh R.
Immunologic Mechanisms of BCc1 Nanomedicine Synthesized by Nanochelating Technology in Breast Tumor-bearing Mice: Immunomodulation and Tumor Suppression
Karimi P., Fakharzadeh S., Kalanaky S., Hafizi M., Hashemi M., Mahdavi M., Nazaran M.
Is Notch Signaling a Specific Target in Hepatocellular Carcinoma?
Sun L., Sun G., Yu Y., H. Coy D.
Microenvironment and Brain Tumor Stem Cell Maintenance: Impact of the Niche
Herold-Mende C., Mock A.
Adenoviral Vectors for Prodrug Activation-based Gene Therapy for Cancer
Doloff J., Waxman D.
Natural Compounds with Cell Growth Inhibitory Activity in Human Tumor Cell Lines
Cazal C., Choosang K., Severino V., Fernandes J., Silva M., Vieira P., Nascimento M., Almeida G., Vasconcelos M., Pakkong P., Pinto M.
Optical and Multimodal Peptide-Based Probes for In Vivo Molecular Imaging
Melendez-Alafort L., Carlo Muzzio P., Rosato A.
Clinical Importance and Potential Use of Small Molecule Inhibitors of Focal Adhesion Kinase
Schultze A., Fiedler W.
Mouse Induced Glioma-Initiating Cell Models and Therapeutic Targets
Kondo T.
Targeting Focal Adhesion Kinase in Neuroblastoma
Gillory L., A. Beierle E.
Glioblastoma as a Novel Drug Repositioning Target: Updated State
Hosseinalizadeh H., Ebrahimi A., Tavakoli A., Monavari S.
Revolutionizing Cancer Treatment: Unleashing the Power of Combining Oncolytic Viruses with CAR-T Cells
Zhang L., Guo S., Chang S., Jiang G.
Small Molecules for Immunomodulation in Cancer: A Review
Iyer V.
Chemically Synthesized Matrix Metalloproteinase and Angiogenesis-inhibiting Peptides as Anticancer Agents
Hu J., Yan M., Pu C., Wang J., Van den Steen P., Opdenakker G., Xu H.
MiR-138 and MiR-135 Directly Target Focal Adhesion Kinase, Inhibit Cell Invasion, and Increase Sensitivity to Chemotherapy in Cancer Cells
Golubovskaya V., Sumbler B., Ho B., Yemma M., Cance W.
Methylenedioxy- and Ethylenedioxy-Fused Indolocarbazoles: Potent Human Topoisomerase I Inhibitors and Antitumor Agents
E. Zembower D., Xie Y., Koohang A., J. Kuffel M., M. Ames M., Zhou Y., Mishra R., Aye Mar A., T. Flavin M., Xu Z.
Downregulation of Hypoxia-related Responses by Novel Antitumor Histone Deacetylase Inhibitors in MDAMB231 Breast Cancer Cells
Naldini A., Filippi I., Cini E., Rodriquez M., Carraro F., Taddei M.
Pancreatic Cancer in Obesity: Epidemiology, Clinical Observations, and Basic Mechanisms
J. Zyromski N., B. White P.
Anti-Cancer Approach with NK4: Bivalent Action and Mechanisms
Nakamura T., Sakai K., Nakamura T., Matsumoto K.
Synthesis and Biological Evaluation of Novel Antifolate Analogs as Potential Anticancer Treatment
F. Stoicescu D., Rotaru M.
Cyclanoline Reverses Cisplatin Resistance in Bladder Cancer Cells by Inhibiting the JAK2/STAT3 Pathway
Li L., Li C., Miao F., Chen W., Kong X., Ye R., Wang F.
Cystine Dimethyl Ester Induces Apoptosis Through Regulation of PKC-δ and PKC-ε in Prostate Cancer Cells
Gurbuz N., Park M., Dent P., Abdel Mageed A., Sikka S., Baykal A.
Nature Promises New Anticancer Agents: Interplay with the Apoptosis-related BCL2 Gene Family
Christodoulou M., Kontos C., Halabalaki M., Skaltsounis A., Scorilas A.
The Effects of β -Glucans on Dendritic Cells and Implications for Cancer Therapy
Albeituni S.H., Yan J.
CCR5 as a Potential Target in Cancer Therapy: Inhibition or Stimulation?
Gonzalez-Martin A., Mira E., Manes S.
Alteration of Ceramide 1-O-Functionalization as a Promising Approach for Cancer Therapy
Ballereau S., Levade T., Genisson Y., Andrieu-Abadie N.
Cellular Redox Modulator, ortho Mn(III) meso-tetrakis(N-n-Hexylpyridinium-2-yl)porphyrin, MnTnHex-2-PyP5+ in the Treatment of Brain Tumors
T. Keir S., W. Dewhirst M., P. Kirkpatrick J., D. Bigner D., Batinic-Haberle I.
Exploiting Cyclooxygenase-(in)Dependent Properties of COX-2 Inhibitors for Malignant Glioma Therapy
H. Schonthal A.
CD36 as a Therapeutic Target in Tumor Microenvironment and Lipid Metabolism
Li J., Chen J., Yang G., Zhang S., Li P., Ye L.
Adenoviral Vectors for Prodrug Activation-based Gene Therapy for Cancer
Doloff J., Waxman D.
Molecular Imaging of Melanoma VEGF-expressing Tumors through [99mTc]Tc-HYNIC-Fab(Bevacizumab)
Fernández M., Reyes A.L., Paolino A., Savio E., Cerecetto H., Cabral P., Gambini J., Camacho X., Perroni C., Alfaya L., Cabrera M., Tassano M., García M.
Synthesis of Nitroaromatic Compounds as Potential Anticancer Agents
Lopes M., de Andrade Sena C., Silva B., de Souza C., Ramos J., Cassali G., de Souza-Fagundes E., Alves R., de Oliveira M., de Oliveira R.
Apoptosis-related BCL2-family Members: Key Players in Chemotherapy
Kontos C., Christodoulou M., Scorilas A.
FAK and Nanog Cross Talk with p53 in Cancer Stem Cells
M. Golubovskaya V.
Antiangiogenic Drugs in the Treatment of Advanced Epithelial Ovarian Cancer
Khosravi-Shahi P., Cabezon-Gutierrez L.
Selective Activation of Intracellular Signalling Pathways in Dendritic Cells for Cancer Immunotherapy
Arce F., Kochan G., Breckpot K., Stephenson H., Escors D.
Strategies for the Biological Evaluation of Gold Anticancer Agents
P. Fricker S.
HLTF Promotes the Proliferation of Osteosarcoma Cells and Cisplatin Resistance
Yu J., Wang C.
MiR-138 and MiR-135 Directly Target Focal Adhesion Kinase, Inhibit Cell Invasion, and Increase Sensitivity to Chemotherapy in Cancer Cells
Golubovskaya V., Sumbler B., Ho B., Yemma M., Cance W.
A Number of the N-terminal RASSF Family: RASSF7
Xu Y., Du W., Xiao Y., Gao K., Li J., Li S.
Viruses and Oral Cancer: Crossreactivity as a Potential Link
Lucchese A.
Orai1 and Transient Receptor Potential Channels as Novel Molecular Targets to Impair Tumor Neovascularization in Renal Cell Carcinoma and other Malignancies
Moccia F., Dragoni S., Poletto V., Rosti V., Tanzi F., Ganini C., Porta C.
A Small-molecule Inhibitor, 5'-O-Tritylthymidine, Targets FAK and Mdm-2 Interaction, and Blocks Breast and Colon Tumorigenesis in vivo
M. Golubovskaya V., L. Palma N., Zheng M., Ho B., Magis A., Ostrov D., G. Cance W.
Anticancer Activity of New Haloalkyl Camptothecin Esters against Human Cancer Cell Lines and Human Tumor Xenografts Grown in Nude Mice
Cao Z., Mendoza J., Kozielski A., Liu X., DeJesus A., Wang Y., Zhan C., Vardeman D., Giovanella B.
Impact of Oncogenic Protein Tyrosine Phosphatases in Cancer
Hardy S., G. Julien S., L. Tremblay M.
Anaplastic Lymphoma Kinase as a Therapeutic Target in Anaplastic Large Cell Lymphoma, Non-Small Cell Lung Cancer and Neuroblastoma
Cheng M., R. Ott G.
Safety and Efficacy of Anlotinib-based Regimen in Patients with Unresectable or Metastatic Bone and Soft-tissue Sarcomas: A Retrospective Institutional Study
Pang L., Zhang S., Wang L., Gong S., He W.
Ivermectin Inhibits Bladder Cancer Cell Growth and Induces Oxidative Stress and DNA Damage
Fan N., Zhang L., Wang Z., Ding H., Yue Z.
1 - 82 of 82 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"